NTRR · CIK 0001512886
NEUTRA CORP.
Annual figures as reported, FY2012–FY2023. Ratios and growth rates derived on-page.
Medicinal Chemicals & Botanical Products
Company profile
Revenue
$68K
▼ −26.1% vs FY2022
Net income
−$561K
▲ +11.3% vs FY2022
Free cash flow
−$446K
▲ +26.8% vs FY2021
Diluted EPS
$0.00
Revenue
Annual, as reported
Net income
Losses shown in terracotta
Recent quarters
momentum · last 12 quartersRevenue — Oct ’23 quarter
$1K
▼ −94.4% vs Oct ’22
Net income — Oct ’23 quarter
−$55K
▲ +32.8% vs Oct ’22
Revenue — trailing 12 months
$17K
▼ −82.7% vs Oct ’22
Quarterly revenue
Discrete quarters; Q4 derived from the annual figure
Quarterly net income
Losses shown in terracotta
| Quarter | Revenue | Rev. YoY | Gross margin | Net income | Net margin | Diluted EPS |
|---|---|---|---|---|---|---|
| Oct ’23 | $1K | −94.4% | 44.9% | −$55K | −4194.2% | — |
| Jul ’23 | $4K | −85.1% | 38.9% | −$72K | −1661.2% | — |
| Apr ’23 | $6K | −39.5% | 48.0% | −$72K | −1232.4% | — |
| Jan ’23 | $6K | −84.6% | 49.9% | −$275K | −4646.1% | — |
| Oct ’22 | $23K | −11.0% | 45.7% | −$82K | −349.8% | — |
| Jul ’22 | $29K | 83.7% | 57.0% | −$97K | −335.6% | — |
| Apr ’22 | $10K | −16.4% | 53.0% | −$107K | −1109.5% | — |
| Jan ’22 | $38K | 1629.0% | 74.9% | −$176K | −457.9% | — |
Profitability & returns
quality of earningsMargins
Share of revenue kept at each line
Gross marginOperating marginNet margin
Returns on capital
Net income vs year-end equity and assets
Cash flow
cash generationFree cash flow
Operating cash flow less capital expenditure
Operating cash flow
Net cash from operations
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Growth rates
compounding, annualizedRevenue CAGR
+119.9%
3y
Key ratios
derived per fiscal year| Fiscal year | Gross margin | Op. margin | Net margin | FCF margin | ROA | Current ratio |
|---|---|---|---|---|---|---|
| FY2023 | 51.9% | −437.8% | −825.7% | — | −746.8% | 0.03× |
| FY2022 | 33.9% | −634.2% | −687.9% | −484.5% | −483.4% | 0.00× |
| FY2021 | −343.3% | −4941.3% | −5563.0% | −6285.4% | −282.5% | 0.02× |
| FY2020 | 100.0% | −6164.9% | −10877.6% | — | −381.5% | 0.18× |
| FY2019 | — | — | — | — | −1485.0% | 0.13× |
| FY2018 | — | — | — | — | −4211.2% | 0.02× |
| FY2017 | — | — | — | — | — | — |
| FY2016 | — | — | — | — | −507971.8% | 0.00× |
| FY2015 | — | — | — | — | −28809.5% | 0.02× |
| FY2014 | — | — | — | — | −2703.0% | 0.14× |
| FY2013 | — | — | — | — | −5151.5% | 0.03× |
| FY2012 | — | — | — | — | −281.5% | 0.46× |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2023 | $68K | $35K | −$298K | −$561K | — | −$153K | — | $75K | $814K | −$774K | $2K | — |
| FY2022 | $92K | $31K | −$584K | −$633K | — | −$406K | $40K | $131K | $1.2M | −$1.3M | $1K | — |
| FY2021 | $10K | −$33K | −$479K | −$539K | $0.00 | −$412K | $196K | $191K | $1.0M | −$967K | $23K | — |
| FY2020 | $6K | $6K | −$394K | −$696K | $0.00 | −$182K | — | $182K | $1.0M | −$849K | $177K | — |
| FY2019 | — | — | −$1.7M | −$2.4M | −$0.16 | −$417K | — | $164K | $1.3M | −$1.1M | $0 | — |
| FY2018 | — | — | −$164K | −$519K | −$0.10 | −$109K | — | $12K | $777K | −$764K | $0 | — |
| FY2017 | — | — | −$371K | −$868K | −$0.41 | −$212K | — | $0 | $676K | −$676K | $0 | — |
| FY2016 | — | — | −$1.0M | −$1.4M | −$1.25 | −$492K | — | $284 | $426K | −$425K | $284 | — |
| FY2015 | — | — | −$636K | −$1.9M | −$3.36 | −$547K | — | $7K | $393K | −$386K | $7K | — |
| FY2014 | — | — | −$966K | −$1.3M | −$0.13 | −$800K | — | $47K | $551K | −$505K | $47K | — |
| FY2013 | — | — | −$308K | −$366K | −$0.16 | −$245K | — | $7K | $272K | −$265K | $7K | — |
| FY2012 | — | — | −$81K | −$81K | −$0.15 | −$68K | — | $29K | $63K | −$34K | $29K | — |
Latest filings
the most recent regulatory filings15-12GNOTICE OF TERMINATION OF REGISTRATION2024-12-12 ↗10-QFORM 10-Q QUARTERLY REPORT FOR 04-30-20242024-08-07 ↗10-KFORM 10-K ANNUAL REPORT FOR 01-31-20242024-08-02 ↗NT 10-QFORM 12B-25 NOTIFICATION OF LATE FILING (NT 10-Q) FOR 04-30-20242024-06-17 ↗8-KFORM 8-K FOR 05-03-20242024-05-15 ↗NT 10-KFORM 12B-25 (NT 10-K) NOTIFICATION OF LATE FILING FOR 01-31-20242024-04-30 ↗10-QFORM 10-Q QUARTERLY REPORT FOR 10-31-20232023-12-15 ↗10-QFORM 10-Q QUARTERLY REPORT FOR 07-31-20232023-09-14 ↗8-KFORM 8-K FOR 08-01-20232023-08-04 ↗10-QFORM 10-Q QUARTERLY REPORT FOR 04-30-20232023-06-22 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.